Jim Cramer’s Latest Calls: 10 Stocks to Buy and Sell Now

2. UnitedHealth Group Inc (NYSE:UNH)

Number of Hedge Fund Investors: 114

Cramer said in a recent program that UnitedHealth Group Inc (NYSE:UNH) has surprisingly been an outperformer on Fed rate cuts.

“But I wouldn’t recommend buying it right here unless the Fed is desperately cutting rates because the economy is falling apart – then you buy UnitedHealth Group Inc (NYSE:UNH). I don’t see that happening.”

UnitedHealth Group Inc (NYSE:UNH) is one of the biggest managed healthcare players globally, with segments like UnitedHealthcare, OptumRx, OptumInsight, and OptumHealth. Analysts believe UNH has strong growth catalysts for 2025 because it may be able to raise prices. BofA expects the company’s EPS to approach $28 this year, with steady growth in the low double digits through 2026. Revenue growth is expected by Wall Street in the range of 7% to 8% annually. While dividends are forecasted to rise by more than 10% each year through 2026, the yield may remain under 2%, and its trailing 12-month free cash flow yield is modest at around 1%. Based on these factors, UnitedHealth Group Inc (NYSE:UNH) forward P/E of 20 looks attractive.

Invesco Growth and Income Fund stated the following regarding UnitedHealth Group Incorporated (NYSE:UNH) in its Q2 2024 investor letter:

“UnitedHealth Group Incorporated (NYSE:UNH): Like many managed care providers, United Health has come under pressure from rising medical costs and higher-than-expected utilization. The stock is currently undervalued based on our analysis. We view the company as a high-quality compounder with secular growth opportunities in the managed care segment. The US Presidential election may cause additional near-term uncertainty, but we believe United Health will be able to rebound once pricing and utilization issues normalize.”